| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/11/2011 | CN101664517B Traditional Chinese medicine for treating encephalitis |
| 05/11/2011 | CN101664087B Health-care liver benefiting tea |
| 05/11/2011 | CN101619315B Functional gene Rdr-lec sequence of rana chensinensis lectin sample, construction method, amino acid sequence thereof and application thereof |
| 05/11/2011 | CN101596193B Application of palmatine in medicine for treating yellow fever virus infection |
| 05/11/2011 | CN101584773B Chinese herbal medicament for treating skin diseases |
| 05/11/2011 | CN101575314B Dihydropyridine compounds and application thereof on preparing drugs for curing and/or preventing virus diseases |
| 05/11/2011 | CN101570760B Recombinant mouse beta-alexin 3 polypeptide, preparation and use thereof |
| 05/11/2011 | CN101564386B Novel applications of pinane amine as M2 inhibitor in pharmacy |
| 05/11/2011 | CN101555252B Synthetic method of antibiotic cefoxitin |
| 05/11/2011 | CN101555249B Method for synthesizing famciclovir |
| 05/11/2011 | CN101549011B Application of tassel herbamoslae in preparing medicaments for treating infectious diseases of beasts and birds |
| 05/11/2011 | CN101503459B Bloody noun antibacterial peptide temporin-Lb, genes thereof and use in pharmacy |
| 05/11/2011 | CN101468970B Nitrone compounds, preparation thereof and use thereof in pharmacy |
| 05/11/2011 | CN101461949B Berberine cyclodextrin inclusion compound, preparation thereof and preparation method |
| 05/11/2011 | CN101444560B Chinese drugs for intractable tinea treatment |
| 05/11/2011 | CN101444513B Cefaclor orally disintegrating tablet and preparation method thereof |
| 05/11/2011 | CN101428143B Attenuated bacteria vector tuberculosis vaccine carrying tuberculosis gene, preparation method and application thereof |
| 05/11/2011 | CN101361969B Therapeutic hepatitis b vaccine and preparation method and use thereof |
| 05/11/2011 | CN101361941B Medicine combination for preventing and treating cold and preparation method thereof |
| 05/11/2011 | CN101342317B Medicament composition for treating tuberculosis and preparation method thereof |
| 05/11/2011 | CN101322782B Novel use of rhizoma typhonii for resisting aids and method for extracting and separating valid part thereof |
| 05/11/2011 | CN101314616B Hemorrhagic bacillus coli of intestine 0157:H7 shiga toxin IIB epitope peptide and uses thereof |
| 05/11/2011 | CN101238135B Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 05/11/2011 | CN101234174B Liquid medicine for treating corn and onychomycosis |
| 05/11/2011 | CN101212983B A vaccine composition comprising alpha-galactosylceramide as an adjuvant for intranasal administration |
| 05/11/2011 | CN101167736B Azithromycin microball preparation and preparation method thereof |
| 05/11/2011 | CN101157717B Preparation method of Ardisia mamillata B and uses thereof |
| 05/11/2011 | CN101152267B Method of preparing anticold grain based on ultrasound wave auxiliary extraction technology |
| 05/11/2011 | CN101147788B Medicine for treating cold and upper respiratory tract infection and its lung inflammation |
| 05/11/2011 | CN101129565B Medicament for treating beriberi, sweaty feet and foot odor |
| 05/11/2011 | CN101100469B Novel crystal of doripenem, preparation method and use thereof |
| 05/11/2011 | CN101081315B Method for forming medical devices containing rapamycin analogs |
| 05/11/2011 | CN101062414B Application of anti-intercellular adhesion molecule-1 monoclonal antibody for preparing medicine for treating avian influenza |
| 05/11/2011 | CN101032486B Medical plants synergist having antifungal activity and drug tolerance of reversion azole antifungal agents |
| 05/10/2011 | US7939667 Hepatitis C inhibitor compounds |
| 05/10/2011 | US7939660 Process and intermediates for preparing emtricitabine |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7939625 Somatostatin analogues |
| 05/10/2011 | US7939492 Factor C for treating gram-negative bacterial infection |
| 05/10/2011 | US7939082 Papilloma virus vaccine |
| 05/10/2011 | CA2572766C Antimicrobial compositions and wound dressings |
| 05/10/2011 | CA2531170C Aztreonam l-lysine and methods for the preparation thereof |
| 05/10/2011 | CA2485535C Modified release pharmaceutical formulation |
| 05/10/2011 | CA2480033C In vivo use of glutathionone s-transferase activated nitric oxide donors |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2467471C Derivatives of andrimid and moiramide b having antibacterial properties |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2460436C Stabilization of active agents by formulation into nanoparticulate form |
| 05/10/2011 | CA2418815C Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/10/2011 | CA2394856C Enzyme treatment for infection |
| 05/10/2011 | CA2306441C Peptides derived from the env gene of the feline immunodeficiency virus and their applications |
| 05/10/2011 | CA2295858C Rhabdoviruses with reengineered coats |
| 05/10/2011 | CA2292898C Bacterial pheromones and uses therefor |
| 05/10/2011 | CA2171589C Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 05/05/2011 | WO2011053798A2 Peptide compositions and methods for inhibiting herpesvirus infection |
| 05/05/2011 | WO2011053789A2 Pharmaceutical composition and methods to enhance cytotoxic t-cell recognition and maintain t-cell memory against a pathogenic disease |
| 05/05/2011 | WO2011053617A1 Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin |
| 05/05/2011 | WO2011052771A1 Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector |
| 05/05/2011 | WO2011052735A1 Antibody having activity of inhibiting infection with hepatitis c virus (hcv) and use of same |
| 05/05/2011 | WO2011052638A1 Process for production of cytokine-induced killer cells |
| 05/05/2011 | WO2011051692A1 Therapeutic peptides |
| 05/05/2011 | WO2011050871A1 Use of menthyl ethers as anti-bacterial, anti-mycotic or anti-viral active substances |
| 05/05/2011 | WO2011050457A1 Stabilized formulation for oral administration of therapeutic agents and related methods |
| 05/05/2011 | WO2011050384A2 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
| 05/05/2011 | WO2011029980A8 Therapeutic compositions for the treatment of hpv-induced diseases |
| 05/05/2011 | WO2010151353A3 Injectable beta-hairpin peptide hydrogel that kills methicillin-resistant staphylococcus aureus |
| 05/05/2011 | WO2010151076A3 Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles |
| 05/05/2011 | WO2010146568A3 Bifidobacteria for treating diabetes and related conditions |
| 05/05/2011 | WO2010135521A3 Compositions and methods for the therapy and diagnosis of influenza |
| 05/05/2011 | WO2010128050A3 Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds |
| 05/05/2011 | WO2010111597A3 Immunodominant compositions and methods of use therefor |
| 05/05/2011 | WO2010012069A8 Multivalent vaccines based on papaya mosaic virus and uses thereof |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105825 Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment |
| 05/05/2011 | US20110105623 Use of methylsulfonylmethane (msm) to modulate microbial activity |
| 05/05/2011 | US20110105620 Organic compounds |
| 05/05/2011 | US20110105597 Modulation of pathogenicity |
| 05/05/2011 | US20110105593 MicroRNA-Formatted Multitarget Interfering RNA Vector Constructs and Methods of Using The Same |
| 05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 05/05/2011 | US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 05/05/2011 | US20110105562 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/05/2011 | US20110105559 Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy |
| 05/05/2011 | US20110105550 Forms of rifaximin and uses thereof |
| 05/05/2011 | US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 05/05/2011 | US20110105546 Spirotropane compounds |
| 05/05/2011 | US20110105531 Compositions and methods for identification of subspecies characteristics of mycobacterium tuberculosis |
| 05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/05/2011 | US20110105525 Pharmaceutical compositions containing a crystalline form of posaconazole |
| 05/05/2011 | US20110105501 Pharmaceutical combinations |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105483 Triazole compounds that modulate hsp90 activity |
| 05/05/2011 | US20110105477 Compositions and methods relating to hiv protease inhibition |
| 05/05/2011 | US20110105473 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105448 Stable Topical Formulation Comprising Voriconazole |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105438 Oligomer-Foscarnet Conjugates |